HomeKLBF • IDX
Kalbe Farma Tbk PT
Rp 1,405.00
Apr 26, 4:40:00 PM GMT+7 · IDR · IDX · Disclaimer
StockID listed security
Previous close
Rp 1,430.00
Day range
Rp 1,405.00 - Rp 1,450.00
Year range
Rp 1,375.00 - Rp 2,200.00
Market cap
65.86T IDR
Avg Volume
29.68M
P/E ratio
23.49
Dividend yield
2.70%
Primary exchange
IDX
Market news
Financials
Income Statement
Revenue
Net income
(IDR)Dec 2023Y/Y change
Revenue
7.89T1.76%
Operating expense
1.88T5.41%
Net income
701.82B-21.73%
Net profit margin
8.90-23.08%
Earnings per share
15.42-20.02%
EBITDA
1.13T-12.71%
Effective tax rate
26.78%
Total assets
Total liabilities
(IDR)Dec 2023Y/Y change
Cash and short-term investments
3.40T-17.02%
Total assets
27.06T-0.67%
Total liabilities
3.94T-23.45%
Total equity
23.12T
Shares outstanding
46.26B
Price to book
3.09
Return on assets
8.97%
Return on capital
10.31%
Net change in cash
(IDR)Dec 2023Y/Y change
Net income
701.82B-21.73%
Cash from operations
1.43T105.94%
Cash from investing
-378.25B58.17%
Cash from financing
-405.88B-234.20%
Net change in cash
515.47B365.52%
Free cash flow
847.59B709.12%
About
PT Kalbe Farma Tbk, or simply known as Kalbe, is an Indonesian pharmaceutical, healthcare and nutrition company established in 1966. The company has expanded by strategic acquisitions of pharmaceutical companies, becoming an integrated consumer health and nutrition enterprise. The Kalbe Group has brands in the prescription drugs, OTC drugs, energy drink and nutrition products, distribution arm that reaches over 1 million outlets. Notably, the company produces misoprostol, a drug which is used to treat stomach ulcers but is also widely used in Indonesia as an illegal abortifacient. Company brands in healthcare and pharmaceutical segments include Promag, Mixagrip, Woods, Komix, Prenagen, Extra Joss and Fitbar. Kalbe is the largest publicly listed pharmaceutical company in Southeast Asia with around US$5 billion in market capitalization and revenues of over Rp 15 trillion. Wikipedia
Founded
Sep 10, 1966
Employees
13,108
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu